APO Research

APO RESEARCH · REPORT

Safety Lancets

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Product & engineering

Understand the product.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Selected research

Industry Research

Safety Lancets Industry Research Report 2026

Market perspective

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Global Safety Lancets key players include BD, Greiner Bio One, B. Braun, etc. Global top 3 manufacturers hold a share over 52%.

Europe is the largest market, with a share about 35%, followed by North America and Asia Pacific, have a share about 30% and 26%.

Read the full market overview

In terms of product, soft blood collection needle is the largest segment, with a share over 77%. And in terms of application, the largest application is hospital and clinics, followed by diagnostic centers.

Report Scope

This report quantifies the global Safety Lancets market in terms of revenue (US$ million) and, where applicable, sales volume (M units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Safety Lancets Market by Company

BD

Greiner Bio One

B. Braun

Terumo

Nipro

Sarstedt

Smiths Medical

贝普医疗科技

三力集团

康德莱

山东威高

广州阳普

Safety Lancets Segment by Type

Soft Blood Collection Needle

Rigid Blood Collection Needle

Safety Lancets Segment by Application

Hospital and Clinics

Diagnostic Centers

Others

Safety Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Safety Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Safety Lancets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Safety Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Safety Lancets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Safety Lancets Sales (M units) of Manufacturers (2021-2026) Table 7. Global Safety Lancets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Safety Lancets Revenue of Manufacturers (2021-2026) Table 9. Global Safety Lancets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Safety Lancets Average Price (USD/K unit) of Manufacturers (2021-2026) Table 11. Global Safety Lancets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Safety Lancets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Safety Lancets, Product Type & Application Table 14. Global Safety Lancets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Safety Lancets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. BD Company Information Table 19. BD Business Overview Table 20. BD Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 21. BD Safety Lancets Product Portfolio Table 22. BD Recent Developments Table 23. Greiner Bio One Company Information Table 24. Greiner Bio One Business Overview Table 25. Greiner Bio One Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 26. Greiner Bio One Safety Lancets Product Portfolio Table 27. Greiner Bio One Recent Developments Table 28. B. Braun Company Information Table 29. B. Braun Business Overview Table 30. B. Braun Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 31. B. Braun Safety Lancets Product Portfolio Table 32. B. Braun Recent Developments Table 33. Terumo Company Information Table 34. Terumo Business Overview Table 35. Terumo Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 36. Terumo Safety Lancets Product Portfolio Table 37. Terumo Recent Developments Table 38. Nipro Company Information Table 39. Nipro Business Overview Table 40. Nipro Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 41. Nipro Safety Lancets Product Portfolio Table 42. Nipro Recent Developments Table 43. Sarstedt Company Information Table 44. Sarstedt Business Overview Table 45. Sarstedt Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 46. Sarstedt Safety Lancets Product Portfolio Table 47. Sarstedt Recent Developments Table 48. Smiths Medical Company Information Table 49. Smiths Medical Business Overview Table 50. Smiths Medical Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 51. Smiths Medical Safety Lancets Product Portfolio Table 52. Smiths Medical Recent Developments Table 53. 贝普医疗科技 Company Information Table 54. 贝普医疗科技 Business Overview Table 55. 贝普医疗科技 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 56. 贝普医疗科技 Safety Lancets Product Portfolio Table 57. 贝普医疗科技 Recent Developments Table 58. 三力集团 Company Information Table 59. 三力集团 Business Overview Table 60. 三力集团 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 61. 三力集团 Safety Lancets Product Portfolio Table 62. 三力集团 Recent Developments Table 63. 康德莱 Company Information Table 64. 康德莱 Business Overview Table 65. 康德莱 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 66. 康德莱 Safety Lancets Product Portfolio Table 67. 康德莱 Recent Developments Table 68. 山东威高 Company Information Table 69. 山东威高 Business Overview Table 70. 山东威高 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 71. 山东威高 Safety Lancets Product Portfolio Table 72. 山东威高 Recent Developments Table 73. 广州阳普 Company Information Table 74. 广州阳普 Business Overview Table 75. 广州阳普 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 76. 广州阳普 Safety Lancets Product Portfolio Table 77. 广州阳普 Recent Developments Table 78. Global Safety Lancets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Safety Lancets Sales by Region (2021-2026) & (M units) Table 80. Global Safety Lancets Sales Market Share by Region (2021-2026) Table 81. Global Safety Lancets Sales by Region (2027-2032) & (M units) Table 82. Global Safety Lancets Sales Market Share by Region (2027-2032) Table 83. Global Safety Lancets Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Safety Lancets Revenue Market Share by Region (2021-2026) Table 85. Global Safety Lancets Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Safety Lancets Revenue Market Share by Region (2027-2032) Table 87. North America Safety Lancets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Safety Lancets Sales by Country (2021-2026) & (M units) Table 89. North America Safety Lancets Sales by Country (2027-2032) & (M units) Table 90. North America Safety Lancets Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Safety Lancets Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Safety Lancets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Safety Lancets Sales by Country (2021-2026) & (M units) Table 94. Europe Safety Lancets Sales by Country (2027-2032) & (M units) Table 95. Europe Safety Lancets Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Safety Lancets Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Safety Lancets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Safety Lancets Sales by Country (2021-2026) & (M units) Table 99. Asia Pacific Safety Lancets Sales by Country (2027-2032) & (M units) Table 100. Asia Pacific Safety Lancets Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Safety Lancets Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Safety Lancets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Safety Lancets Sales by Country (2021-2026) & (M units) Table 104. South America Safety Lancets Sales by Country (2027-2032) & (M units) Table 105. South America Safety Lancets Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Safety Lancets Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Safety Lancets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Safety Lancets Sales by Country (2021-2026) & (M units) Table 109. Middle East and Africa Safety Lancets Sales by Country (2027-2032) & (M units) Table 110. Middle East and Africa Safety Lancets Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Safety Lancets Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Safety Lancets Sales by Type (2021-2026) & (M units) Table 113. Global Safety Lancets Sales by Type (2027-2032) & (M units) Table 114. Global Safety Lancets Sales Market Share by Type (2021-2026) Table 115. Global Safety Lancets Sales Market Share by Type (2027-2032) Table 116. Global Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Safety Lancets Revenue Market Share by Type (2021-2026) Table 119. Global Safety Lancets Revenue Market Share by Type (2027-2032) Table 120. Global Safety Lancets Price by Type (2021-2026) & (USD/K unit) Table 121. Global Safety Lancets Price by Type (2027-2032) & (USD/K unit) Table 122. Global Safety Lancets Sales by Application (2021-2026) & (M units) Table 123. Global Safety Lancets Sales by Application (2027-2032) & (M units) Table 124. Global Safety Lancets Sales Market Share by Application (2021-2026) Table 125. Global Safety Lancets Sales Market Share by Application (2027-2032) Table 126. Global Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Safety Lancets Revenue Market Share by Application (2021-2026) Table 129. Global Safety Lancets Revenue Market Share by Application (2027-2032) Table 130. Global Safety Lancets Price by Application (2021-2026) & (USD/K unit) Table 131. Global Safety Lancets Price by Application (2027-2032) & (USD/K unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Safety Lancets Distributors List Table 135. Safety Lancets Customers List Table 136. Safety Lancets Industry Trends Table 137. Safety Lancets Industry Drivers Table 138. Safety Lancets Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Safety Lancets Product Image Figure 5. Global Safety Lancets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Safety Lancets Market Size (2021-2032) & (US$ Million) Figure 7. Global Safety Lancets Sales (2021-2032) & (M units) Figure 8. Global Safety Lancets Average Price (USD/K unit) & (2021-2032) Figure 9. Soft Blood Collection Needle Product Image Figure 10. Rigid Blood Collection Needle Product Image Figure 11. Hospital and Clinics Product Image Figure 12. Diagnostic Centers Product Image Figure 13. Others Product Image Figure 14. Global Safety Lancets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Safety Lancets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Safety Lancets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Safety Lancets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Safety Lancets Sales by Region in 2025 Figure 20. Global Safety Lancets Revenue by Region in 2025 Figure 21. North America Safety Lancets Market Size by Country in 2025 Figure 22. North America Safety Lancets Sales Market Share by Country (2021-2032) Figure 23. North America Safety Lancets Revenue Market Share by Country (2021-2032) Figure 24. United States Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Safety Lancets Market Size by Country in 2025 Figure 28. Europe Safety Lancets Sales Market Share by Country (2021-2032) Figure 29. Europe Safety Lancets Revenue Market Share by Country (2021-2032) Figure 30. Germany Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Safety Lancets Market Size by Country in 2025 Figure 41. Asia Pacific Safety Lancets Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Safety Lancets Revenue Market Share by Country (2021-2032) Figure 43. China Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Safety Lancets Market Size by Country in 2025 Figure 52. South America Safety Lancets Sales Market Share by Country (2021-2032) Figure 53. South America Safety Lancets Revenue Market Share by Country (2021-2032) Figure 54. Brazil Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Safety Lancets Market Size by Country in 2025 Figure 58. Middle East and Africa Safety Lancets Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Safety Lancets Revenue Market Share by Country (2021-2032) Figure 60. Egypt Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Safety Lancets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Safety Lancets Sales Market Share by Type (2021-2032) Figure 66. Global Safety Lancets Revenue Market Share by Type (2021-2032) Figure 67. Global Safety Lancets Price (USD/K unit) by Type (2021-2032) Figure 68. Global Safety Lancets Sales Market Share by Application (2021-2032) Figure 69. Global Safety Lancets Revenue Market Share by Application (2021-2032) Figure 70. Global Safety Lancets Price (USD/K unit) by Application (2021-2032) Figure 71. Safety Lancets Value Chain Figure 72. Safety Lancets Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Safety Lancets Industry Opportunities and Challenges

Scope & coverage.

Types
  • Soft Blood Collection Needle
  • Rigid Blood Collection Needle
Applications
  • Hospital and Clinics
  • Diagnostic Centers
  • Others
Companies covered
  • BD
  • Greiner Bio One
  • B. Braun
  • Terumo
  • Nipro
  • Sarstedt
  • Smiths Medical
  • 贝普医疗科技
  • 三力集团
  • 康德莱
  • 山东威高
  • 广州阳普

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Safety Lancets Market Size (2021-2032)
  4. 2.2.2 Global Safety Lancets Sales (2021-2032)
  5. 2.2.3 Global Safety Lancets Market Average Price (2021-2032)
  6. 2.3 Safety Lancets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Soft Blood Collection Needle
  9. 2.3.3 Rigid Blood Collection Needle
  10. 2.4 Safety Lancets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital and Clinics
  13. 2.4.3 Diagnostic Centers
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Safety Lancets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Safety Lancets Sales (M units) of Manufacturers (2021-2026)
  3. 3.3 Global Safety Lancets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Safety Lancets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Safety Lancets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Safety Lancets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Safety Lancets, Product Type & Application
  8. 3.8 Global Manufacturers of Safety Lancets, Established Date
  9. 3.9 Global Safety Lancets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 BD
  2. 4.1.1 BD Company Information
  3. 4.1.2 BD Business Overview
  4. 4.1.3 BD Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 BD Safety Lancets Product Portfolio
  6. 4.1.5 BD Recent Developments
  7. 4.2 Greiner Bio One
  8. 4.2.1 Greiner Bio One Company Information
  9. 4.2.2 Greiner Bio One Business Overview
  10. 4.2.3 Greiner Bio One Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Greiner Bio One Safety Lancets Product Portfolio
  12. 4.2.5 Greiner Bio One Recent Developments
  13. 4.3 B. Braun
  14. 4.3.1 B. Braun Company Information
  15. 4.3.2 B. Braun Business Overview
  16. 4.3.3 B. Braun Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 B. Braun Safety Lancets Product Portfolio
  18. 4.3.5 B. Braun Recent Developments
  19. 4.4 Terumo
  20. 4.4.1 Terumo Company Information
  21. 4.4.2 Terumo Business Overview
  22. 4.4.3 Terumo Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Terumo Safety Lancets Product Portfolio
  24. 4.4.5 Terumo Recent Developments
  25. 4.5 Nipro
  26. 4.5.1 Nipro Company Information
  27. 4.5.2 Nipro Business Overview
  28. 4.5.3 Nipro Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Nipro Safety Lancets Product Portfolio
  30. 4.5.5 Nipro Recent Developments
  31. 4.6 Sarstedt
  32. 4.6.1 Sarstedt Company Information
  33. 4.6.2 Sarstedt Business Overview
  34. 4.6.3 Sarstedt Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sarstedt Safety Lancets Product Portfolio
  36. 4.6.5 Sarstedt Recent Developments
  37. 4.7 Smiths Medical
  38. 4.7.1 Smiths Medical Company Information
  39. 4.7.2 Smiths Medical Business Overview
  40. 4.7.3 Smiths Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Smiths Medical Safety Lancets Product Portfolio
  42. 4.7.5 Smiths Medical Recent Developments
  43. 4.8 贝普医疗科技
  44. 4.8.1 贝普医疗科技 Company Information
  45. 4.8.2 贝普医疗科技 Business Overview
  46. 4.8.3 贝普医疗科技 Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 贝普医疗科技 Safety Lancets Product Portfolio
  48. 4.8.5 贝普医疗科技 Recent Developments
  49. 4.9 三力集团
  50. 4.9.1 三力集团 Company Information
  51. 4.9.2 三力集团 Business Overview
  52. 4.9.3 三力集团 Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 三力集团 Safety Lancets Product Portfolio
  54. 4.9.5 三力集团 Recent Developments
  55. 4.10 康德莱
  56. 4.10.1 康德莱 Company Information
  57. 4.10.2 康德莱 Business Overview
  58. 4.10.3 康德莱 Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 康德莱 Safety Lancets Product Portfolio
  60. 4.10.5 康德莱 Recent Developments
  61. 4.11 山东威高
  62. 4.11.1 山东威高 Company Information
  63. 4.11.2 山东威高 Business Overview
  64. 4.11.3 山东威高 Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 山东威高 Safety Lancets Product Portfolio
  66. 4.11.5 山东威高 Recent Developments
  67. 4.12 广州阳普
  68. 4.12.1 广州阳普 Company Information
  69. 4.12.2 广州阳普 Business Overview
  70. 4.12.3 广州阳普 Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 广州阳普 Safety Lancets Product Portfolio
  72. 4.12.5 广州阳普 Recent Developments
5 Global Safety Lancets Market Scenario by Region
  1. 5.1 Global Safety Lancets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Safety Lancets Sales by Region: 2021-2032
  3. 5.2.1 Global Safety Lancets Sales by Region: 2021-2026
  4. 5.2.2 Global Safety Lancets Sales by Region: 2027-2032
  5. 5.3 Global Safety Lancets Revenue by Region: 2021-2032
  6. 5.3.1 Global Safety Lancets Revenue by Region: 2021-2026
  7. 5.3.2 Global Safety Lancets Revenue by Region: 2027-2032
  8. 5.4 North America Safety Lancets Market Facts & Figures by Country
  9. 5.4.1 North America Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Safety Lancets Sales by Country (2021-2032)
  11. 5.4.3 North America Safety Lancets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Safety Lancets Market Facts & Figures by Country
  16. 5.5.1 Europe Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Safety Lancets Sales by Country (2021-2032)
  18. 5.5.3 Europe Safety Lancets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Safety Lancets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Safety Lancets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Safety Lancets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Safety Lancets Market Facts & Figures by Country
  41. 5.7.1 South America Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Safety Lancets Sales by Country (2021-2032)
  43. 5.7.3 South America Safety Lancets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Safety Lancets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Safety Lancets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Safety Lancets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Safety Lancets Sales by Type (2021-2032)
  2. 6.1.1 Global Safety Lancets Sales by Type (2021-2032) & (M units)
  3. 6.1.2 Global Safety Lancets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Safety Lancets Revenue by Type (2021-2032)
  5. 6.2.1 Global Safety Lancets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Safety Lancets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Safety Lancets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Safety Lancets Sales by Application (2021-2032)
  2. 7.1.1 Global Safety Lancets Sales by Application (2021-2032) & (M units)
  3. 7.1.2 Global Safety Lancets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Safety Lancets Revenue by Application (2021-2032)
  5. 7.2.1 Global Safety Lancets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Safety Lancets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Safety Lancets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Safety Lancets Value Chain Analysis
  2. 8.1.1 Safety Lancets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Safety Lancets Production Mode & Process
  5. 8.2 Safety Lancets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Safety Lancets Distributors
  8. 8.2.3 Safety Lancets Customers
9 Global Safety Lancets Analyzing Market Dynamics
  1. 9.1 Safety Lancets Industry Trends
  2. 9.2 Safety Lancets Industry Drivers
  3. 9.3 Safety Lancets Industry Opportunities and Challenges
  4. 9.4 Safety Lancets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research